UK Has Sought Advice On Compulsory Licensing For Vertex’ Orkambi

Pressure on Vertex over access to its cystic fibrosis drug Orkambi in England is mounting after the parliamentary undersecretary for health admitted the government has already taken advice on compulsory licensing of the product.